35,089 XNAS Volume
XNAS 20 Mar, 2025 4:00 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| John Aballi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.47 per share. | 28 Feb 2025 | 8,621 | 746,214 (5%) | 0% | 2.5 | 21,251 | Common Stock |
| Jeffrey G. Black | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 15,000 | 289,492 (2%) | 0% | 0 | Common Stock | |
| Jeffrey G. Black | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 10,000 | 10,000 | - | - | Stock Option(right to buy) | |
| John Aballi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 112,500 | 737,593 (5%) | 0% | 0 | Common Stock | |
| John Aballi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 75,000 | 75,000 | - | - | Stock Option(right to buy) | |
| Jeffrey G. Black | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.98 per share. | 15 Nov 2024 | 22,298 | 274,492 (2%) | 0% | 3.0 | 66,448 | Common Stock |
| John Aballi | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.81 per share. | 14 Nov 2024 | 24,305 | 689,799 (5%) | 0% | 2.8 | 68,297 | Common Stock |
| Jeffrey G. Black | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2024 | 225,000 | 252,194 (2%) | 1% | 0 | Common Stock | |
| Paul Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Ana Hooker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Frank Stokes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Scott D. Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option(right to buy) | |
| John Aballi | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.92 per share. | 16 May 2024 | 40,401 | 40,401 (0%) | 0% | 1.9 | 77,570 | Common Stock |
| Kamal Adawi | CFO and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 1.91 per share. | 04 Mar 2024 | 9,297 | 247,236 (1%) | 0% | 1.9 | 17,747 | Common Stock |
| Kamal Adawi | CFO and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 1.91 per share. | 04 Mar 2024 | 3,487 | 243,749 (1%) | 0% | 1.9 | 6,660 | Common Stock |
| John Aballi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.91 per share. | 29 Feb 2024 | 9,804 | 600,788 (4%) | 0% | 1.9 | 18,726 | Common Stock |
| John Aballi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 175,000 | 590,984 (4%) | 1% | 0 | Common Stock | |
| Kamal Adawi | CFO and Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 75,000 | 256,533 (2%) | 0% | 0 | Common Stock | |
| Adawi Kamal | CFO and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 1.95 per share. | 06 Feb 2024 | 6,738 | 181,533 (1%) | 0% | 1.9 | 13,133 | Common Stock |
| Paul Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 15,000 | 15,000 | - | - | Stock Option(right to buy) | |
| James L.L. Tullis | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.11 per share. | 15 Jun 2023 | 167 | 1,515,839 (12%) | 0% | 3.1 | 519 | Common Stock |
| Wendy S. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Ana Hooker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Frank Stokes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Brian Birk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Ebetuel Pallares | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Kamal Adawi | CFO and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 2.30 per share. | 02 Mar 2023 | 3,667 | 188,271 (1%) | 0% | 2.3 | 8,432 | Common Stock |
| Mark Hazeltine | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Mar 2023 | 3,667 | 190,205 (1%) | 0% | 0 | Common Stock | |
| Kamal Adawi | CFO and Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 100,000 | 191,938 (1%) | 0% | 0 | Common Stock | |
| Mark Hazeltine | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 100,000 | 193,872 (1%) | 0% | 0 | Common Stock | |
| Kamal Adawi | CFO and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 2.69 per share. | 08 Feb 2023 | 5,821 | 91,938 (0%) | 0% | 2.7 | 15,671 | Common Stock |
| Mark Hazeltine | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 2.69 per share. | 08 Feb 2023 | 5,821 | 93,872 (0%) | 0% | 2.7 | 15,672 | Common Stock |
| John Aballi | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.68 per share. | 08 Dec 2022 | 90,000 | 440,000 (3%) | 0% | 2.7 | 241,200 | Common Stock |
| John Aballi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2022 | 350,000 | 350,000 | - | 0 | Restricted Stock Units | |
| James L.L. Tullis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Wendy S. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Ana Hooker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Frank Stokes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Brian Birk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Ebetuel Pallares | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Fortunato Ron Rocca | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.12 per share. | 01 Mar 2022 | 4,322 | 120,678 (0%) | 0% | 7.1 | 30,773 | Common Stock |
| Kamal Adawi | CFO and Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.12 per share. | 01 Mar 2022 | 3,241 | 97,759 (0%) | 0% | 7.1 | 23,076 | Common Stock |
| Debra Zack | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.12 per share. | 01 Mar 2022 | 3,241 | 84,259 (0%) | 0% | 7.1 | 23,076 | Common Stock |
| Mark Hazeltine | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.12 per share. | 01 Mar 2022 | 3,241 | 99,693 (0%) | 0% | 7.1 | 23,076 | Common Stock |
| Fortunato Ron Rocca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 75,000 | 125,000 (0%) | 0% | 0 | Common Stock | |
| Kamal Adawi | CFO and Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 63,500 | 101,000 (0%) | 0% | 0 | Common Stock | |
| Debra Zack | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 50,000 | 87,500 (0%) | 0% | 0 | Common Stock | |
| Mark Hazeltine | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 63,500 | 102,934 (0%) | 0% | 0 | Common Stock | |
| Wendy S. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 14.02 per share. | 03 Sep 2021 | 1,000 | 1,000 (0%) | 0% | 14.0 | 14,020 | Common Stock |
| James L.L. Tullis | Director | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 05 Aug 2021 | 6,800 | 1,515,672 (12%) | 0% | 10.7 | 72,863 | Common Stock |
| James L.L. Tullis | Director | Sale of securities on an exchange or to another person at price $ 11.92 per share. | 02 Aug 2021 | 1,800 | 1,528,872 (12%) | 0% | 11.9 | 21,454 | Common Stock |
| James L.L. Tullis | Director | Sale of securities on an exchange or to another person at price $ 11.77 per share. | 02 Aug 2021 | 4,300 | 1,524,572 (12%) | 0% | 11.8 | 50,618 | Common Stock |
| James L.L. Tullis | Director | Sale of securities on an exchange or to another person at price $ 11.39 per share. | 02 Aug 2021 | 2,100 | 1,522,472 (12%) | 0% | 11.4 | 23,917 | Common Stock |
| Ana Hooker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2021 | 15,000 | 15,000 | - | - | Stock Option(right to buy) | |
| James L.L. Tullis | Director | Sale of securities on an exchange or to another person at price $ 16.03 per share. | 25 Jun 2021 | 8,763 | 1,546,909 (12%) | 0% | 16.0 | 140,503 | Common Stock |
| James L.L. Tullis | Director | Sale of securities on an exchange or to another person at price $ 14.67 per share. | 25 Jun 2021 | 5,379 | 1,530,672 (12%) | 0% | 14.7 | 78,910 | Common Stock |
| James L.L. Tullis | Director | Sale of securities on an exchange or to another person at price $ 14.98 per share. | 25 Jun 2021 | 10,858 | 1,536,051 (12%) | 0% | 15.0 | 162,696 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Wendy S. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Frank Stokes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option(right to buy) | |
| Brian Birk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Ebetuel Pallares | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Mark Hazeltine | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2021 | 1,934 | 1,061 | - | - | Stock Option(right to buy) | |
| Mark Hazeltine | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.26 per share. | 17 May 2021 | 1,934 | 39,434 (0%) | 0% | 0.3 | 503 | Common Stock |
| Fortunato Ron Rocca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Fortunato Ron Rocca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 40,000 | 40,000 | - | - | Stock Option(right to buy) | |
| Kamal Adawi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 12,500 | 12,500 | - | - | Stock Option(right to buy) | |
| Kamal Adawi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 37,500 | 37,500 (0%) | 0% | 0 | Common Stock | |
| Debra Zack | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 12,500 | 12,500 | - | - | Stock Option(right to buy) | |
| Debra Zack | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 37,500 | 37,500 (0%) | 0% | 0 | Common Stock | |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 05 Feb 2021 | 3,000 | 21,348 (0%) | 0% | 17 | 51,000 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.56 per share. | 15 Jan 2021 | 257 | 24,348 (0%) | 0% | 15.6 | 3,998 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.51 per share. | 15 Jan 2021 | 1,014 | 24,605 (0%) | 0% | 15.5 | 15,725 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.58 per share. | 13 Jan 2021 | 4,000 | 25,619 (0%) | 0% | 15.6 | 62,320 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.74 per share. | 13 Jan 2021 | 1,729 | 29,619 (0%) | 0% | 15.7 | 27,214 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.23 per share. | 15 Dec 2020 | 12,000 | 1,555,672 (12%) | 0% | 12.2 | 146,726 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.03 per share. | 10 Dec 2020 | 10,000 | 1,575,172 (12%) | 0% | 14.0 | 140,300 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.04 per share. | 10 Dec 2020 | 7,500 | 1,567,672 (12%) | 0% | 13.0 | 97,775 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.21 per share. | 09 Nov 2020 | 882 | 31,348 (0%) | 0% | 16.2 | 14,293 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.88 per share. | 15 Oct 2020 | 4,316 | 34,429 (0%) | 0% | 14.9 | 64,226 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.02 per share. | 15 Oct 2020 | 198 | 32,127 (0%) | 0% | 16.0 | 3,171 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.25 per share. | 15 Oct 2020 | 2,104 | 32,325 (0%) | 0% | 16.2 | 34,180 | Common Stock |
| Wendy S. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 15,000 | 15,000 | - | - | Stock Option(right to buy) | |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.40 per share. | 11 Sep 2020 | 15,000 | 1,585,275 (12%) | 0% | 12.4 | 186,000 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.95 per share. | 14 Aug 2020 | 1,398 | 38,745 (0%) | 0% | 17.0 | 23,697 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.52 per share. | 14 Aug 2020 | 2,082 | 1,600,275 (12%) | 0% | 14.5 | 30,221 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.95 per share. | 14 Aug 2020 | 11,507 | 1,602,357 (12%) | 0% | 17.0 | 195,052 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Jeffrey T. Elliott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Brian Birk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Chet Burrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Ebetuel Pallares | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.91 per share. | 09 Jun 2020 | 4,782 | 1,613,864 (12%) | 0% | 12.9 | 61,735 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.77 per share. | 09 Jun 2020 | 578 | 40,143 (0%) | 0% | 12.8 | 7,383 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.77 per share. | 09 Jun 2020 | 1,522 | 1,618,646 (12%) | 0% | 12.8 | 19,440 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.57 per share. | 27 May 2020 | 605 | 41,569 (0%) | 0% | 12.6 | 7,607 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.93 per share. | 27 May 2020 | 848 | 40,721 (0%) | 0% | 11.9 | 10,117 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.93 per share. | 27 May 2020 | 2,240 | 1,620,168 (12%) | 0% | 11.9 | 26,724 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.57 per share. | 27 May 2020 | 1,595 | 1,622,408 (12%) | 0% | 12.6 | 20,055 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 May 2020 | 582 | 42,174 (0%) | 0% | 0 | Common Stock | |
| James L.L. Tullis | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 May 2020 | 1,162 | 1,624,003 (12%) | 0% | 0 | Common Stock | |
| Ebetuel Pallares | Director | Other type of transaction at price $ 0.00 per share. | 13 Apr 2020 | 144,033 | 0 (0%) | 1% | 0 | Common Stock | |
| Ebetuel Pallares | Director | Other type of transaction at price $ 0.00 per share. | 13 Apr 2020 | 1,185 | 1,185 (0%) | 0% | 0 | Common Stock | |
| Debra Zack | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2020 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| James L.L. Tullis | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Mar 2020 | 164,420 | 1,625,165 (12%) | 1% | 0 | Common Stock | |
| Ebetuel Pallares | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.51 per share. | 11 Mar 2020 | 2,112 | 141,982 (1%) | 0% | 19.5 | 41,199 | Common Stock |
| Ebetuel Pallares | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.84 per share. | 11 Mar 2020 | 22,427 | 144,094 (1%) | 0% | 1.8 | 41,266 | Common Stock |
| Ebetuel Pallares | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2020 | 2,265 | 0 | - | - | Warrants | |
| Ebetuel Pallares | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2020 | 22,427 | 0 | - | - | Warrants | |
| Ebetuel Pallares | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.50 per share. | 11 Mar 2020 | 214 | 144,033 (1%) | 0% | 19.5 | 4,174 | Common Stock |
| Ebetuel Pallares | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.84 per share. | 11 Mar 2020 | 2,265 | 144,247 (1%) | 0% | 1.8 | 4,168 | Common Stock |
| Fortunato Ron Rocca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2020 | 155,000 | 155,000 | - | - | Stock Option(right to buy) | |
| Kamal Adawi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2020 | 52,500 | 52,500 | - | - | Stock Option(right to buy) | |
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 742,761 | 0 | - | - | Series H Redeemable Convertible Preferred Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 833,333 | 0 | - | - | Series F Redeemable Convertible Preferred Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 262,821 | 0 | - | - | Series F Redeemable Convertible Preferred Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 6,895,096 | 0 | - | - | Series F Redeemable Convertible Preferred Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 53,251,030 | 0 | - | - | Series E Redeemable Convertible Preferred Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 5,446,902 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 468,321 | 0 | - | - | Series A-3 Redeemable Convertible Preferred Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 11,498 | 0 | - | - | Warrants | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 11,498 | 11,597 (0%) | 0% | 14.3 | 164,692 | Common Stock | |
| James L.L. Tullis | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.58 per share. | 19 Sep 2019 | 8,865 | 2,732 (0%) | 0% | 18.6 | 164,712 | Common Stock |
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 41,591 | 41,592 (0%) | 0% | 0 | Common Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 1,431 | 1,431 (0%) | 0% | 0 | Common Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 4,537 | 4,537 (0%) | 0% | 0 | Common Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 1,786,853 | 1,789,585 (14%) | 14% | 0 | Common Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 58,359,932 | 0 | - | - | Series H Redeemable Convertible Preferred Stock | ||
| James L.L. Tullis | Director, Ten Percent Owner | 19 Sep 2019 | 81,166,226 | 0 | - | - | Series F Redeemable Convertible Preferred Stock | ||
| Ebetuel Pallares | None | 19 Sep 2019 | 4,423,371 | 0 | - | - | Series E Redeemable Convertible Preferred Stock | ||
| Ebetuel Pallares | None | 19 Sep 2019 | 120,609 | 121,667 (1%) | 1% | 0 | Common Stock | ||
| Ebetuel Pallares | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.58 per share. | 19 Sep 2019 | 2,960 | 1,058 (0%) | 0% | 18.6 | 54,997 | Common Stock |
| Ebetuel Pallares | None | 19 Sep 2019 | 3,839 | 4,018 (0%) | 0% | 14.3 | 54,988 | Common Stock | |
| Ebetuel Pallares | None | 19 Sep 2019 | 7,970,686 | 0 | - | - | Series F Redeemable Convertible Preferred Stock | ||
| Ebetuel Pallares | None | 19 Sep 2019 | 3,839 | 0 | - | - | Warrants | ||
| Jeffrey T. Elliott | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2019 | 13,613 | 13,613 | - | - | Stock Option (right to buy) | |
| Fortunato Ron Rocca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2019 | 138,659 | 138,659 | - | - | Stock Option(right to buy) | |
| Kamal Adawi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2019 | 21,635 | 21,635 | - | - | Stock Option (right to buy) | |
| Thierry Dervieux | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2019 | 10,891 | 10,891 | - | - | Stock Option (right to buy) | |
| Chet Burrell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2019 | 13,613 | 13,613 | - | - | Stock Option (right to buy) |